Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Livermore

Showing results (31-40 of 245) with videos related to

Pageof 25
Sort By:
The West Indian Medical Journal|June 12, 2001
Facing antibiotic resistanceD M Livermore
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Acquired carbapenemasesD M Livermore
Current Opinion in Microbiology|October 26, 2000
Carbapenemases: a problem in waiting?D M Livermore, N Woodford
The Journal of Antimicrobial Chemotherapy|January 1, 1994
Zinc ions and medium-dependent susceptibility to beta-lactams in Xanthomonas maltophiliaG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|September 1, 1988
Activity of temocillin and other penicillins against beta-lactamase-inducible and -stably derepressed enterobacteriaY Yang, D M Livermore
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 10, 2007
Antibiotic resistance: location, location, locationD M Livermore, A Pearson
The Journal of Antimicrobial Chemotherapy|March 1, 1994
beta-Lactamase types amongst Staphylococcus aureus isolates in relation to susceptibility to beta-lactamase inhibitor combinationsG Bonfiglio, D M Livermore
The Lancet. Infectious Diseases|March 2, 2002
Can we beat MRSA now we know its genome sequence?N Woodford, D M Livermore
The Journal of Antimicrobial Chemotherapy|September 1, 1996
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in EuropeD M Livermore, M Yuan
The Journal of Antimicrobial Chemotherapy|June 1, 1991
Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin D M Livermore, P Seetulsingh
Pageof 25

Showing results (31-40 of 245) with videos related to

Sort By:
Pageof 25
The West Indian Medical Journal|June 12, 2001
Facing antibiotic resistanceD M Livermore
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Acquired carbapenemasesD M Livermore
Current Opinion in Microbiology|October 26, 2000
Carbapenemases: a problem in waiting?D M Livermore, N Woodford
The Journal of Antimicrobial Chemotherapy|January 1, 1994
Zinc ions and medium-dependent susceptibility to beta-lactams in Xanthomonas maltophiliaG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|September 1, 1988
Activity of temocillin and other penicillins against beta-lactamase-inducible and -stably derepressed enterobacteriaY Yang, D M Livermore
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 10, 2007
Antibiotic resistance: location, location, locationD M Livermore, A Pearson
The Journal of Antimicrobial Chemotherapy|March 1, 1994
beta-Lactamase types amongst Staphylococcus aureus isolates in relation to susceptibility to beta-lactamase inhibitor combinationsG Bonfiglio, D M Livermore
The Lancet. Infectious Diseases|March 2, 2002
Can we beat MRSA now we know its genome sequence?N Woodford, D M Livermore
The Journal of Antimicrobial Chemotherapy|September 1, 1996
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in EuropeD M Livermore, M Yuan
The Journal of Antimicrobial Chemotherapy|June 1, 1991
Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin D M Livermore, P Seetulsingh
Pageof 25